DERM
Journey Medical Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.86
−0.51%Margins
Gross margin
62.2%
EBITDA margin
2.7%
EBIT margin
-4.4%
Net margin
-9.0%
FCF margin
-11.0%
-19.0%
Return on equity
-6.2%
Return on assets
-5.2%
Return on invested capital
0.72x
Asset turnover
-$7.5M
Cash from operations
$0.91
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026